Search

Your search keyword '"Enouf V"' showing total 164 results

Search Constraints

Start Over You searched for: Author "Enouf V" Remove constraint Author: "Enouf V"
164 results on '"Enouf V"'

Search Results

5. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

6. First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022

8. First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022

9. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

11. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

14. Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies

16. Estimation of seasonal influenza vaccine effectiveness using data collected in primary care in France: comparison of the test-negative design and the screening method

17. The potential risks and impact of the start of the 2015-2016 influenza season in the WHO European Region: a rapid risk assessment

21. First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013

29. Molecular epidemiology of clade 1 influenza A viruses (H5N1), southern Indochina peninsula, 2004-2007.

30. Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020

31. First cases of middle east respiratory syndrome coronavirus (MERS-COV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013

33. Influenza at the animal–human interface: a review of the literature for virological evidence of human infection with swine or avian influenza viruses other than A(H5N1)

34. Start of the 2014/15 influenza season in Europe: Drifted influenza A(H3N2) viruses circulate as dominant subtype

36. The value of open-source clinical science in pandemic response

37. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

38. COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

39. Molecular Epidemiology of Clade 1 Influenza A Viruses (H5N1), Southern Indochina Peninsula, 2004–2007

40. Serological responses against seasonal influenza viruses in patients with multiple myeloma treated or untreated with daratumumab after two doses of tetravalent vaccine.

41. Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023-24: a modelling study.

42. COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.

43. COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.

44. Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024.

45. Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.

46. Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.

47. Investigations into SARS-CoV-2 and other coronaviruses on mink farms in France late in the first year of the COVID-19 pandemic.

48. One Health compartment analysis of ESBL-producing Escherichia coli reveals multiple transmission events in a rural area of Madagascar.

49. Emergence and evolution of the Omicron SARS-CoV-2 variant in the island of Martinique.

50. Investigations on SARS-CoV-2 and other coronaviruses in mink farms in France at the end of the first year of COVID-19 pandemic.

Catalog

Books, media, physical & digital resources